LENZ Therapeutics (LENZ) Inventory Average (2022 - 2026)

LENZ Therapeutics (LENZ) has 4 years of Inventory Average data on file, last reported at $3.2 million in Q1 2026.

• Inventory Average for Q1 2026 came in at $3.2 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $3.2 million (changed N/A YoY), and the FY2022 annual result was $2.2 million, up 54.84% from the prior year.
• Inventory Average advanced to $3.2 million in Q1 2026 per LENZ's latest filing, from $1.9 million in the prior quarter.
• Over five years, Inventory Average peaked at $3.2 million in Q1 2026 and troughed at $1.1 million in Q2 2023.
• A 4-year average of $2.1 million and a median of $2.0 million in 2022 frame the typical range for Inventory Average.
• On a YoY basis, Inventory Average climbed as much as 29.71% in 2023 and fell as far as 37.33% in 2023.
• A 4-year view of Inventory Average shows it stood at $2.5 million in 2022, then sank by 57.54% to $1.1 million in 2023, then jumped by 84.82% to $1.9 million in 2025, then surged by 65.61% to $3.2 million in 2026.
• Business Quant data shows LENZ's Inventory Average at $3.2 million in Q1 2026, $1.9 million in Q4 2025, and $1.1 million in Q2 2023.